This session will explore the intricate relationships within gut flora and the factors influencing microbial diversity. Researchers will present findings on how these dynamics affect gastrointestinal health and disease.

This track focuses on the therapeutic potential of probiotics in managing gastrointestinal disorders. Presentations will cover clinical trials, mechanisms of action, and the impact of probiotics on gut microbiota.

This session will delve into the role of prebiotics in modulating gut microbiota and enhancing health outcomes. Experts will discuss the biochemical pathways through which prebiotics exert their effects.

This track will highlight recent advancements in microbial therapy for gastrointestinal diseases. Presentations will include case studies and novel therapeutic approaches targeting the microbiome.

This session will examine the complex interactions between the immune system and gut microbiota. Researchers will present data on how these interactions influence health and disease susceptibility.

This track will focus on cutting-edge sequencing technologies used to analyze gut microbiota. Discussions will include methodological advancements and their implications for understanding gastrointestinal health.